Publication
Essential Corporate News: Week ending December 3, 2021
On November 26, 2021 the Financial Conduct Authority (FCA) published Policy Statement PS21/16, summarising feedback to a Consultation Paper (CP21/25) it published in July 2021
The impact of the GDPR on clinical trial research
Global | Publication | October 2018
In April 2016, the European Parliament adopted the General Data Protection Regulation (GDPR) to modernize its data protection legislation. As of May 25, 2018, the Data Protection Directive was thus repealed and replaced by the GDPR, while all member states legislation became subject to review to be aligned with the GDPR, leading to major modifications of the rules that prevailed prior to the GDPR coming into force.
For research trials, enacting the GDPR had a number of implications, both for sponsors, contract research organizations (CROs) and trial sites located in the European Union (EU), and for some foreign CROs and sponsors, which now need to comply with various obligations failing which they may be exposed to heavy fines and other legal recourses.
Click here to read about the various obligations that must be complied with.
Contacts
Managing Partner, Québec Office
Global Co-Head of Life Sciences and Healthcare; Partner
Partner, Canadian Head of Life Sciences and Healthcare
Recent publications
Publication
Top EU court bans investors from suing member states in arbitration
Recent decisions by the Court of Justice of the European Union (CJEU), the EU’s top court, have abolished the rights that EU investors previously had to bring claims against EU member states in international arbitration.
Subscribe and stay up to date with the latest legal news, information and events...